Scott Gottlieb, MD
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- My op-ed on the large shift of drug discovery moving to China and policy steps the U.S. can take to keep the innovation economy in America. "Five years ago, U.S. drug makers didn’t license any new drugs from China. By 2024, one-third came from Chinese biotech"
- Survey from MassBio and Biocom: “Of the 88 companies who responded, 50% of respondents reported at least one tangible impact from the FDA's reduction in workforce. This is all within the first 17 days following the RIF.” Reporting via Eric Schmidt of Cantor
- Whooping cough cases are rising, and doctors are bracing for another tough year. There have been 8,485 cases reported so far in 2025, according to preliminary data from the CDC. That’s twice as many cases as this time last year. apnews.com/article/whoo...
- Steve Usdin writing in BioCentury: “It’s official: FDA says its cuts are delaying drug regulation — Layoffs, lack of access to journals slow response FDA says”
- This FDA office enabled all of the first time generic drug approvals in the U.S. Their work helped substantially lower drug costs and increase competition during President Trump’s first term, including spearheading approval of the first generic EpiPen in 2018. This office has now been eliminated
- FDA planning for fewer food and drug inspections due to layoffs, officials say
- My segment on CBSNews.com Face the Nation from Sunday
- I’ll be on Face the Nation tomorrow discussing the latest developments in healthcare policy
- My segment today on cnbc.com on Trump Administration’s new plan to improve biosecurity on poultry farms to reduce outbreaks of avian influenza, and additional steps we may take to mitigate risk as wild birds return to migratory flyways this spring
- Reposted by Scott Gottlieb, MDRFK Jr.'s comments on vitamin A and cod liver oil as treatments for measles are "extremely damaging because the impression it leaves to consumers is that there is a treatment available for measles, when in fact there is not," former FDA head @scottgottliebmd.bsky.social says at #STATBreakthrough:
- My op ed in STAT News on bird flu, egg shortages, vaccines, and FDA regulation — and additional steps we can take ahead of the spring migration season, when wild birds return to North American flighways, and the risk of outbreaks in poultry farms may rise
- Measles outbreak in the U.S. continues to expand with 39 new cases in Texas (198 total) and 20 new cases in New Mexico (30 total) h/t BNO News
- My segment on CNBC today on the expanding measles outbreak in Texas and the risk of further spread m.youtube.com/watch?v=Zl7w...
- My segment from CBS News Face the Nation from Sunday, where I discussed the growing measles outbreak in the Southwest
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- I’m on @facethenation.bsky.social this Sunday discussing latest developments related to avian flu and efforts to alleviate egg shortage, the ongoing Measles outbreak, and other health topics
- ‘Texas Measles Outbreak Nears 100 Cases, Raising Concerns About Undetected Spread’ @kffhealthnews.org
- Study suggests that, under certain circumstances, H5N1 avian influenza may be spread between poultry farms through aerosolized feces or dander from infected birds www.cnn.com/2025/02/18/h...
- Update on the Texas Measles outbreak: Cases doubled this week, with 48 known infections now, most in patients are under the age of 17. All of the cases are believed to have occurred in unvaccinated individuals, with 13 people hospitalized www.dshs.texas.gov/news-alerts/...
- We’re experiencing perhaps the worst flu season in 25 years, with severe cases also rising, and young children and seniors faring the worst. One in six of all ER visits in the 0-17 age groups are now for influenza. www.cdc.gov/fluview/surv... h/t @cmyeaton.bsky.social
- Fox News: “Texas confirms growing measles outbreak affecting school-aged children”
- My essay in JAMA today on targeted reforms that FDA could make to help facilitate the adoption of AI to high value clinical applications inside electronic medical records — to improve physician precision and productivity, and patient outcomes jamanetwork.com/journals/jam...
- My op ed from the New York Times in August on steps the U.S. can take to stem the flow of fentanyl. Many of the fentanyl precursor chemicals are shipped directly into U.S. from China and then transferred to Mexico for processing. A key step is choking off supply of these chemicals at their source
- My @cnbc.com appearance today commenting on Mr. Kennedy’s hearings and nomination, and my public public health concerns.
- My segment on @cnbc.com on the ensuing cough and cold season, and vaccine policy in the U.S.
- My segment from @cnbc.com today on the incoming Trump Administration and policies they're likely to pursue to promote drug price competition, advance innovation, and reduce the growing shift of early drug discovery and development work from the U.S. to China
- I’m coming up on CNBC at 10:50 from the inauguration booth in Washington, with host Becky Quick, discussing the Trump Administration’s healthcare agenda and the outlook for innovation and continued advances in life sciences. @cnbc.com #TrumpInauguration
- For the first time in 12 years, Rhode Island has reported a case of the measles.
- I’ll be on @cnbc.com Monday from the inauguration booth with host Becky Quick discussing the Trump Administration’s healthcare agenda, coming policy changes, and the outlook for innovation and continued advances in life sciences. #TrumpInauguration
- From Lena Sun at @washingtonpost.com. ‘Bird flu almost killed this13-year-old girl. “You can only survive if you’re that sick in a modern pediatric ICU,” one doctor said. This is what doctors and public health experts fear if H5N1 evolves into a pandemic.’
- 👏👏 This is a good decision by the FDA. This is first and only nicotine pouch product authorized by the FDA, providing an important opportunity to help currently addicted adult smokers transition to alternative nicotine products that don’t have all the harmful effects of combustible cigarettes.
- My article from a decade ago on vaccine hesitancy, the anti-vax movement, and the risk of a measles resurgence in the U.S. As relevant today as it was when this article was first published by Forbes.
- This is a key step toward the broader vision outlined by FDA: leveraging the tools of product regulation to shift the market away from combustible cigarettes and—for adults who still want to use nicotine—enable access to properly regulated, non-combustible alternatives such as pouches and e-cigs
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- Robust disease surveillance for novel pathogens isn’t just a matter of public health preparedness, but also national security, and need to guard against deliberate threats. As the tools for engineering dangerous pathogens become more ubiquitous, threats increase My essay in @statnews.com
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- My essay today in @statnews.com on the national security imperative for maintaining robust disease surveillance tools. (with Dr. Mark McClellan)
- My segment today on @cnbc.com on bird flu preparations. Among the things we should consider is stockpiling the full range of antiviral drugs targeting influenza, including Xofluza and Amantadine. Recent case reports showed the virus was able to mutate around Tamiflu. 1/2
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- Reposted by Scott Gottlieb, MD[Not loaded yet]
- My Op Ed in Sunday @washingtonpost.com with Dr. Lu Borio on steps we need to take to better prepare in the event bird flu begins to circulate in humans; and past failings in our approaches to these kinds of risks that we need to learn and correct from
- My Op Ed in Sunday Washington Post with Dr. Lu Borio (online now) on steps we need to take to better prepare in the event bird flu begins to circulate in humans; and past failings in our approaches to these kinds of risks that we need to learn and correct from
- My segment on @cnbc.com today m.youtube.com/watch?v=oUJk...
- I’m combing up on @cnbc.com at 7:30 AM where I’ll be discussing cough and cold season, along with emerging pathogens like H5N1 and steps to mitigate these potential risks.
